161 related articles for article (PubMed ID: 2645067)
1. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
Kostrzewa RM; Saleh MI
Brain Res Dev Brain Res; 1989 Jan; 45(1):95-101. PubMed ID: 2645067
[TBL] [Abstract][Full Text] [Related]
2. Impaired striatal dopamine receptor development: differential D-1 regulation in adults.
Saleh MI; Kostrzewa RM
Eur J Pharmacol; 1988 Sep; 154(3):305-11. PubMed ID: 3069481
[TBL] [Abstract][Full Text] [Related]
3. MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny.
Saleh MI; Kostrzewa RM
Peptides; 1989; 10(1):35-9. PubMed ID: 2568624
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
Kostrzewa RM; Saleh MI
Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
[TBL] [Abstract][Full Text] [Related]
5. Effect of unilateral perinatal hypoxic-ischemic brain injury on striatal dopamine uptake sites and D1 and D2 receptors in adult rats.
Kostic VS; Przedborski S; Jackson-Lewis V; Cadet JL; Burke RE
Neurosci Lett; 1991 Aug; 129(2):197-200. PubMed ID: 1836054
[TBL] [Abstract][Full Text] [Related]
6. Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors.
O'Boyle KM; Gavin KT; Harrison N
J Recept Res; 1993; 13(1-4):329-39. PubMed ID: 8450496
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
[TBL] [Abstract][Full Text] [Related]
8. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
9. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
11. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
[TBL] [Abstract][Full Text] [Related]
13. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.
Cross AJ; Mashal RD; Johnson JA; Owen F
Neuropharmacology; 1983 Nov; 22(11):1327-9. PubMed ID: 6141534
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
Srivastava LK; Mishra RK
Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Wiener HL; Lajtha A; Sershen H
Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
[TBL] [Abstract][Full Text] [Related]
16. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
17. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
Tedford CE; Crosby G; Iorio LC; Chipkin RE
Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
[TBL] [Abstract][Full Text] [Related]
18. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
20. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
